🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The primary purpose of this study is to determine whether locally advanced ...
Status
Completed
Location
NSABP Foundation, Inc.
Start Date
2001-11
Trial ID
NCT00378313
Treatments Being Tested
The study consists in a co-clinical trial by using zebrafish embryos. Speci...
Status
Unknown
Location
Azienda Ospedaliero-Universitaria Pisana
Start Date
2018-06-01
Trial ID
NCT03668418
Remarkable progress has been made in treating germ-cell tumor (GCT) through...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-11-11
Trial ID
NCT06470464
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Queen Elizabeth Hospital at University of Birmingham
Start Date
2001-08
Trial ID
NCT00039546
Treatments Being Tested
In this trial we will evaluate ABI-007 with gemcitabine and epirubicin, uti...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2005-09
Trial ID
NCT00193206
Treatments Being Tested
Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2014-04-07
Trial ID
NCT02299999
RATIONALE: Drugs used in chemotherapy, such as epirubicin, cyclophosphamide...
Status
Unknown
Location
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust
Start Date
2005-01
Trial ID
NCT00070278
Advancements in systemic antineoplastic therapies have led to improved over...
Status
Not Yet Recruiting
Location
CHU Brugmann
Start Date
2026-06-01
Trial ID
NCT07545486
Treatments Being Tested
This is a Phase 1B/2, non-randomized, dose-escalation, multicenter, open-la...
Status
Terminated
Location
Multiple Locations
Start Date
2009-09-25
Trial ID
NCT00954512